JP2023540350A5 - - Google Patents

Info

Publication number
JP2023540350A5
JP2023540350A5 JP2023515095A JP2023515095A JP2023540350A5 JP 2023540350 A5 JP2023540350 A5 JP 2023540350A5 JP 2023515095 A JP2023515095 A JP 2023515095A JP 2023515095 A JP2023515095 A JP 2023515095A JP 2023540350 A5 JP2023540350 A5 JP 2023540350A5
Authority
JP
Japan
Prior art keywords
alkyl
compound according
c6alkyl
substituted
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023515095A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023540350A (ja
JP7811578B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/049003 external-priority patent/WO2022051583A1/en
Publication of JP2023540350A publication Critical patent/JP2023540350A/ja
Publication of JP2023540350A5 publication Critical patent/JP2023540350A5/ja
Application granted granted Critical
Publication of JP7811578B2 publication Critical patent/JP7811578B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023515095A 2020-09-03 2021-09-03 中環状または大環状ベンジル置換複素環誘導体およびオレキシン-2受容体アゴニストとしてのそれらの使用 Active JP7811578B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063074220P 2020-09-03 2020-09-03
US63/074,220 2020-09-03
PCT/US2021/049003 WO2022051583A1 (en) 2020-09-03 2021-09-03 Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and their uses as orexin-2 receptor agonists

Publications (3)

Publication Number Publication Date
JP2023540350A JP2023540350A (ja) 2023-09-22
JP2023540350A5 true JP2023540350A5 (cg-RX-API-DMAC7.html) 2024-10-02
JP7811578B2 JP7811578B2 (ja) 2026-02-05

Family

ID=78078371

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023515095A Active JP7811578B2 (ja) 2020-09-03 2021-09-03 中環状または大環状ベンジル置換複素環誘導体およびオレキシン-2受容体アゴニストとしてのそれらの使用

Country Status (6)

Country Link
US (1) US20230331720A1 (cg-RX-API-DMAC7.html)
EP (1) EP4208465A1 (cg-RX-API-DMAC7.html)
JP (1) JP7811578B2 (cg-RX-API-DMAC7.html)
CN (1) CN116635393A (cg-RX-API-DMAC7.html)
TW (1) TW202227433A (cg-RX-API-DMAC7.html)
WO (1) WO2022051583A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20260083444A (ko) 2019-11-25 2026-06-05 알케르메스,인코포레이티드 치환된 마크로사이클릭 화합물 및 관련 치료 방법
US12503475B2 (en) 2020-09-03 2025-12-23 Centessa Pharmaceuticals (Uk) Limited Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists
US12006330B2 (en) 2020-12-21 2024-06-11 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
WO2022207935A1 (en) 2021-04-02 2022-10-06 Orexia Therapeutics Limited 2-(3-ethynylbenzyl)-substituted heterocycle derivatives as orexin-2 agonists
JP7833486B2 (ja) * 2021-05-26 2026-03-19 アルカーメス,インコーポレイテッド 置換されるカルバメート大環状化合物および関連のある治療方法
WO2023167925A1 (en) * 2022-03-01 2023-09-07 Orexia Therapeutics Limited Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related uses
US20260116891A1 (en) * 2022-04-22 2026-04-30 Teijin Pharma Limited Oxazepin Derivative
CN114716319B (zh) * 2022-04-28 2024-03-26 浙江工业大学 一种联芳氧基烯酸酯类化合物的合成方法
EP4600242A1 (en) * 2022-10-07 2025-08-13 Kissei Pharmaceutical Co., Ltd. Cyclopentane compound
TW202432109A (zh) 2022-10-31 2024-08-16 日商武田藥品工業股份有限公司 食慾素2型受體促效劑之給藥
EP4680611A1 (en) 2023-03-16 2026-01-21 Takeda Pharmaceutical Company Limited Macrocyclic heterocycle compounds and use thereof
JP2026518313A (ja) 2023-06-01 2026-06-04 ハー・ルンドベック・アクチエゼルスカベット スピロ大環状オレキシン2受容体アゴニスト
TW202502342A (zh) 2023-06-02 2025-01-16 日商武田藥品工業股份有限公司 食慾素2受體促效劑用於改善睡眠期間之呼吸功能的用途
UY40937A (es) * 2023-10-20 2025-04-30 Teijin Pharma Ltd Cristal de derivado de oxazepina o cristal de solvato del mismo
CN122374291A (zh) 2023-12-12 2026-07-10 爱杜西亚药品有限公司 作为食欲素受体调节剂的芳基砜及砜酮衍生物
WO2025132542A1 (en) 2023-12-19 2025-06-26 Idorsia Pharmaceuticals Ltd Macrocyclic orexin agonists
WO2025229493A1 (en) 2024-04-29 2025-11-06 Takeda Pharmaceutical Company Limited Dosing of orexin type 2 receptor agonists
US20260144795A1 (en) 2024-11-27 2026-05-28 H. Lundbeck A/S Spiromacrocyclic orexin 2 receptor agonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
US10428023B2 (en) * 2017-08-03 2019-10-01 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
PE20211700A1 (es) * 2019-01-31 2021-09-01 Takeda Pharmaceuticals Co Compuesto heterociclico y su uso
KR20260083444A (ko) * 2019-11-25 2026-06-05 알케르메스,인코포레이티드 치환된 마크로사이클릭 화합물 및 관련 치료 방법

Similar Documents

Publication Publication Date Title
ES2660831T3 (es) Derivados de imidazol condensados útiles como inhibidores de IDO
JP7431900B2 (ja) (s)-3-(4-((4-(モルホリノメチル)ベンジル)オキシ)-1-オキソイソインドリン-2-イル)ピペリジン-2,6-ジオンの塩及び固体形態、並びにそれらを含有する組成物及び使用方法
KR101593242B1 (ko) 6-, 7- 또는 8-치환된 퀴나졸리논 유도체, 및 그를 포함하는 조성물 및 그의 사용 방법
JP6359563B2 (ja) 3−(5置換−4−オキソキナゾリン−3(4h)−イル)−3−ジュウテロピペリジン−2,6−ジオン誘導体
JP2023527575A5 (cg-RX-API-DMAC7.html)
JP2025507852A5 (cg-RX-API-DMAC7.html)
JP5959543B2 (ja) 3−(5−アミノ−2−メチル−4−オキソ−4h−キナゾリン−3−イル)−ピペリジン−2,6−ジオンの固体形態、並びにそれらの医薬組成物及び使用
JP2018502891A5 (cg-RX-API-DMAC7.html)
CN103382197A (zh) N-甲基氨甲基异吲哚化合物和包含它的组合物及其使用方法
JP2007508361A5 (cg-RX-API-DMAC7.html)
JP2019529490A5 (cg-RX-API-DMAC7.html)
RU2011137419A (ru) Обратные агонисты и антагонисты гистамина н3 и способы их применения
KR102304111B1 (ko) 베타-클로로시클로펜탄의 친수성 에스테르 전구약물의 이용에 의한 감소된 중심 각막 비후
JP2014528485A5 (cg-RX-API-DMAC7.html)
JP2014526469A5 (cg-RX-API-DMAC7.html)
JPH05320142A (ja) 中枢神経系に薬理活性をもつ化合物
JP2009526831A5 (cg-RX-API-DMAC7.html)
EP3893945A1 (en) Cromolyn esters and uses thereof
TW201215605A (en) Manufacturing process for pyrimidine derivatives
WO2014129495A1 (ja) 眼疾患処置薬
JP2019532069A5 (cg-RX-API-DMAC7.html)
RU2019111188A (ru) Кетоновые ингибиторы лизин-специфичного гингипаина
CN105658634B (zh) 作为TCR-Nck相互作用的抑制剂的被醇盐取代的色烯衍生物
KR100292928B1 (ko) 치환된헥사하이드로벤조페난트리딘
JP2017525684A5 (cg-RX-API-DMAC7.html)